Physician
Total Patient Care of Ocala, INC.
Total Patient Care of Ocala, INC. was paid $1.01M by Medicaid between Jan 2018 and Nov 2024, across 17 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 56% of everything it billed.
33Billing provider infoTOTAL PATIENT CARE OF OCALA, INC.
OCALA, FL 34474
OCALA, FL 34474
33aNPI1174863757assigned 02/19/2013
33bProvider typeAddiction Medicine (Anesthesiology) Physician
28Total paid$1.01M
24GClaims53,868
24DCodes billed17
24AFirst – last monthJan 2018 – Nov 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,106 | $4K | |
| 2019 | 12,438 | $265K | |
| 2020 | 6,833 | $141K | |
| 2021 | 5,143 | $95K | |
| 2022 | 10,020 | $218K | |
| 2023 | 8,221 | $148K | |
| 2024incomplete | 9,107 | $141K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 56% | 20,572 | 17,840 | $570K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 15% | 3,482 | 2,769 | $149K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 3,994 | 3,723 | $135K |
| 80305 | 10% | 22,922 | 19,986 | $104K | |
| 99205 | Prolong outpt/office vis | 4.0% | 405 | 353 | $41K |
| 62323 | <1% | 79 | 56 | $5K | |
| 20610 | <1% | 78 | 41 | $4K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 26 | 26 | $3K |
| 99406 | <1% | 477 | 403 | $1K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 571 | 402 | $820.76 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 762 | 529 | $417.40 |
| 99408 | <1% | 135 | 121 | $41.51 |
5 more codes
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 84 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 18 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 123 | $0.00 |
| J3490 | Unclassified drugs | 0% | 124 | $0.00 |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSACHER, MARK (CEO)